Physician profile
Ryan E Hunt
NPI 1134547615
$1,149.23
in general payments reported to CMS, 2019-2025
10 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $129 · 2021: $26.81 · 2023: $375 · 2024: $301 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.56 |
| Travel and Lodging | $234.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $356.30 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Arthrex, INC. | $295.15 | 2019-2023 | |
| Novo Nordisk INC | $215.81 | 2019-2021 | |
| Cdc Medical LLC | $96.45 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $92.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.07 | 2020 | |
| Si-Bone, INC. | $23.47 | 2025 | |
| Bioventus LLC | $15.61 | 2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $13.73 | 2025 | Blueprint Patient Specific Instrumentation |
| Amarin Pharma, INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.